Loading chat...
IA SF552
Bill
Status
3/6/2025
Primary Sponsor
Health And Human Services
Click for details
AI Summary
-
Department of Health and Human Services and Department of Administrative Services must review anti-obesity medications, including GLP-1 agonists, for the Medicaid program and state employee health insurance plans
-
Review criteria includes effectiveness for weight loss, impact on comorbidities, potential cost savings from deferred medical procedures and reduced medications, recommended eligibility requirements, and short-term and long-term coverage costs
-
Joint report required to be submitted to the Iowa General Assembly by January 5, 2026, containing findings, proposed eligibility requirements, and associated costs
Legislative Description
A bill for an act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for state employees.(Formerly SSB 1138.)
Last Action
Referred to Health and Human Services. S.J. 1058.
6/16/2025